This Healthcare Stock Defied Gravity in its Heyday: Today, it Is Undervalued

Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) remains undervalued as results are bottoming and the stock rallies on recovering revenue and a slowly improving balance sheet.

| More on:

If Bausch Health Companies (TSX:BHC)(NYSE:BHC) was a buy back in 2015 (as per many analysts back then) at over $200 and even $300 a share, when debt levels were spiraling out of control, P/E multiples were in the mid-30s, and the company had a debt-to-EBITDA ratio that was untenable, what is it today after it has taken steps to address these issues and more?

Let’s take a look at what’s changed with this healthcare stock.

Although debt levels are still untenable, they have at least been managed better by instituting a company-wide goal of reducing debt and managing maturities and interest expenses — something the company’s new CEO Joseph Papa has been adamant about.

Re-financing at lower interest rates, slowly paying down debt with excess cash flow, and limiting new debt issuances have been key moves to get the debt situation under control.

Net debt was reduced by over $100 million in the most recent quarter, and although this is pretty insignificant relative to total debt on the books of over $23 billion, it is at least progress in the right direction. Three years ago, the company’s debt levels were north of $30 billion.

Furthermore, the practice of instituting sharp and egregious price increases has been scaled back with the help of regulatory pressure, and after the SEC got after the company about its accounting practices, the company’s books are being put in order.

So, with this, the company can start to get back to the business of running a profitable healthcare company that has its stakeholders’ best interests at heart, including patients in need of medical care and the company’s shareholders.

Revenue turning the corner

First-quarter total revenue came in at just over $2 billion, which represents a 4% constant-currency increase, as revenue inches its way back up after falling off a cliff in the years leading up to 2018.

Valuation still attractive

After trading at multiples as highs as over 30 times back in its heyday, Bausch stock is now trading at P/E multiples of below 10 times.

And although the company is a fraction of what it was, with revenue roughly 20% lower today compared to 2015, and EPS roughly 59% lower these days compared to 2015, we can see a bottoming of these numbers and the light at the end of the tunnel.

Final thoughts

While Bausch’s recovery remains in early stages, the healthcare sector is booming, as the population is aging rapidly, and so healthcare needs and spending will see a sustained upward trend.

The company is resolving litigation, which is removing some clouds over its stock. It is slowly reducing debt, removing another cloud. And its valuation still does not reflect much good news and actually appears undervalued for this powerhouse.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Investing

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

rising arrow with flames
Investing

2 Riskier Stocks With High Potential for Canadian Investors in November

Risky stocks such as Well Health Technologies have the potential to provide life-changing long-term returns.

Read more »

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »

senior man and woman stretch their legs on yoga mats outside
Dividend Stocks

TFSA: 2 Canadian Stocks to Buy and Hold Forever

Here are 2 TFSA-worthy Canadian stocks. Which one is a good buy for your TFSA today?

Read more »

Canada day banner background design of flag
Investing

Got $500? 5 Top Canadian Stocks to Buy and Hold

These top Canadian stocks have solid fundamentals with potential to outperform the benchmark index by a wide margin.

Read more »

man touches brain to show a good idea
Energy Stocks

1 No-Brainer Energy Stock to Buy With $500 Right Now

Should you buy a cyclical energy stock at its decade-high? Probably not. But read this before you make a decision.

Read more »

Asset Management
Stocks for Beginners

TFSA: 4 Canadian Stocks to Buy and Hold Forever

Thinking about what to buy with the new TFSA contribution space in 2025? These four Canadian stocks are worth holding…

Read more »